Physician

Al Jonathan Lee, D.O.

According to 2025 Medicare claims, Al Lee, D.O. (NPI: 1104266089) practices nephrology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is NEPHROLOGY & HYPERTENSION ASSOCIATES PC (NPI: 1417980954; TIN: 232767597) and primary practice location at 19047-1295.

Lee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 489 traditional Medicare patients, billed 1,511 HCPCS/CPT codes, and received $137,236 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,626 prescription claims across 253 beneficiaries totaling $60,334 in drug costs, led by Amlodipine-Valsartan-Hctz (Amlodipine/Valsartan/Hcthiazid). 2023 DME data shows 60 claims. Open Payments data shows 22 records totaling $477. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $4,859 to $60,334. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	265	776	$85,707
2019	545	1,660	$200,585
2020	516	1,728	$179,057
2021	492	1,351	$183,608
2022	523	1,393	$166,833
2023	447	1,841	$160,213
2024	489	1,511	$137,236

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	36	69	$4,859
2016	25	55	$3,245
2017	24	94	$6,828
2018	39	137	$4,513
2019	86	325	$22,408
2020	115	733	$49,563
2021	159	839	$67,725
2022	210	1,032	$62,747
2023	221	1,078	$79,772
2024	253	1,626	$60,334

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	86	$28,101
2022	N/R	48	$27,345
2023	N/R	60	$29,069
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	176	189	$137
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	92	146	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	149	246	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	111	156	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	92	129	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Amlodipine-Valsartan-Hctz	Amlodipine/Valsartan/Hcthiazid	16	1,140	$10,486
Irbesartan	Irbesartan	163	10,310	$4,340
Valsartan	Valsartan	94	5,340	$2,526
Carvedilol	Carvedilol	203	10,770	$1,474
Amlodipine Besylate	Amlodipine Besylate	102	5,640	$781

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$477	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Al Jonathan Lee, D.O.?

Tedicare shows public-source Medicare data for Al Jonathan Lee, D.O. (NPI 1104266089), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Al Jonathan Lee, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Al Jonathan Lee, D.O.?

Al Jonathan Lee, D.O. is linked to NEPHROLOGY & HYPERTENSION ASSOCIATES PC (billing NPI 1417980954) in the available physician profile data.

Does Al Jonathan Lee, D.O. have Open Payments data?

Al Jonathan Lee, D.O. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.